// App-Quantinova.ai

261 : A randomized trial of abiraterone acetate (AA) administered with 1 of 4 glucocorticoid (GC) regimens in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).

Researchers

Presenter

  • Gerhardt Attard

Principal Investigators

  • Axel S. Merseburger

  • Cora N. Sternberg

  • Linda Cerbone

  • Federica Recine

  • Robert J. Jones

  • Susan Feyerabend

  • Alfredo Berruti

  • Steven Joniau

  • Peter Schatteman

  • Lajos Geczi

  • Peter Tenke

  • Patrick Werbrouck

  • Florence Lefresne

  • Florence Nave Shelby

  • Marjolein Lahaye

  • Corinna Pick

  • Bertrand F. Tombal

Medical Centers

  • The Institute of Cancer Research & The Royal Marsden, London, Spain

  • Department of Dermatology University of Lubeck, Lubeck, Germany

  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy

  • University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Studienpraxis Urologie, Nurtingen, Germany

  • Medical Oncology, University of Brescia, Spedali Civili Hospital, Brescia, Italy

  • Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium

  • Chemotherapy C and Clinical Pharmacology Department, National Institute of Oncology, Budapest, Hungary

  • Jahn Ferenc Dél-Pesti Kórház, Urology Department, Budapest, Hungary

  • AZ Groeninge, Kortrijk, Belgium

  • Janssen-Cilag, Paris, France

  • Janssen-Cilag BV, Tilburg, Netherlands

  • Janssen-Cilag GmbH, Neuss, Germany

  • Institut de Recherche Clinique, Universite Catholique de Louvain, Brussels, Belgium

Locations

  • United Kingdom

  • Germany

  • Italy

  • Belgium

  • Hungary

  • France

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

  • Cardiovascular (CVS)

Disease

  • Metastatic castration-resistant prostate cancer

  • Hypertension

  • Solid malignancies

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • CB-7598

  • Glucocorticoid

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Ketoconazole

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multicenteric

Phase

  • II

Study Id's

  • NCT01867710

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved